tiprankstipranks
Trending News
More News >
IQE PLC (GB:IQE)
LSE:IQE
UK Market

IQE plc (IQE) AI Stock Analysis

Compare
71 Followers

Top Page

GB:IQE

IQE plc

(LSE:IQE)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
10.50p
▲(108.75% Upside)
The score is primarily held down by weak financial performance, including ongoing losses, very low gross margin, and deteriorating cash flow alongside rising leverage. Technicals are supportive with strong momentum above moving averages, but the extremely overbought RSI/Stoch readings add pullback risk. Valuation is constrained by negative earnings (negative P/E), with no dividend data to offset the risk profile.
Positive Factors
Leading supplier of advanced semiconductor materials
IQE's status as a specialist supplier of epitaxial wafers and substrates represents a durable business-model advantage. Its technical know‑how and manufacturing capability for compound semiconductors create high barriers to entry, supporting long-term customer stickiness and premium product demand.
Exposure to 5G, IoT and optical device tailwinds
Structural adoption of 5G, IoT and optical applications increases advanced-material content per device. IQE’s product mix aligns with these multi-year secular trends, supporting sustained addressable-market growth and the potential for higher-volume, recurring supply agreements over the medium term.
Diversified revenue streams & research partnerships
A mix of long-term supply contracts, project work and R&D collaborations reduces single-customer risk and supports a steady innovation pipeline. Partnerships with tech firms and institutions enhance product development and provide durable routes to commercialization and repeatable revenue.
Negative Factors
Very low gross margin
A 3.77% gross margin is structurally constraining: it implies limited ability to cover fixed costs, invest in R&D or absorb pricing pressure. Unless manufacturing yields or pricing improve, sustained low gross margins will hinder profitability and capital allocation flexibility over the medium term.
Deteriorating cash generation and negative free cash flow
Persistent negative free cash flow and weak operating cash conversion limit the company’s ability to self-fund capex, scale production or pursue strategic investments. Continued cash burn increases reliance on external financing and constrains long-term operational and strategic flexibility.
Rising leverage with negative returns
Higher leverage combined with negative ROE raises financial risk: debt servicing burdens can amplify earnings volatility and reduce resilience in downturns. This profile can force restrictive liquidity management or dilutive financing choices that impair long-term shareholder value creation.

IQE plc (IQE) vs. iShares MSCI United Kingdom ETF (EWC)

IQE plc Business Overview & Revenue Model

Company DescriptionIQE plc develops, manufactures, and sells advanced semiconductor materials. The company operates in three segments: Wireless, Photonics, and CMOS++. It manufactures compound semiconductor wafers or epiwafers using epitaxy process; offers wireless products, including GaAs, GaN, and InP-based technologies, as well as Si and Ge-based epitaxial wafer structures; and supplies GaAs HBTs, pHEMTs, and BiFETs/BiHEMTs for use in consumer mobile handsets, connected devices, 5G network infrastructure, WiFi 6, Bluetooth, and satellite communications. The company also provides photonics products, which include vertical cavity surface emitting lasers, a 3D sensing technology that enables facial recognition, gesture control, light detection and ranging (LiDAR), and other advanced sensing applications; indium phosphide (InP) laser and detector wafers that powers high speed, 5G telecommunication, and data communication fiber optic networks; Gallium Nitride (GaN) and gallium arsenide (GaSb) for multicolor uLED displays; and a range of gallium antimonide (GaSb) and InP materials that enables high definition infrared imaging and sensing in security, health monitoring, and environmental applications. In addition, it offers substrate products, such as GaSb, InP, InAs, InSb, GaSb, CZT, custom size or geometry wafers, polycrystalline materials, high purity group iii/v source materials, and bespoke orientation substrates. Further, the company provides nanoimprint lithography services. The company serves in the United States, rest of the Americas, France, Germany, Israel, the United Kingdom, rest of Europe, the Middle East, Africa, the People's Republic of China, Japan, Taiwan, and rest of the Asia-Pacific. IQE plc was founded in 1988 and is headquartered in Cardiff, the United Kingdom.
How the Company Makes MoneyIQE generates revenue primarily through the sale of its semiconductor materials, particularly epitaxial wafers, to a diverse customer base including major technology companies and device manufacturers. The company's revenue model is driven by the high demand for advanced materials in emerging technologies such as 5G telecommunications and Internet of Things (IoT) applications. Key revenue streams include long-term supply agreements with customers, project-based sales for specialized semiconductor applications, and collaborations with research institutions for developing innovative materials. Significant partnerships with leading tech firms and collaborations in research and development also contribute to IQE's earnings by enhancing its product offerings and expanding its market reach.

IQE plc Earnings Call Summary

Earnings Call Date:May 13, 2025
(Q4-2024)
|
% Change Since: |
Next Earnings Date:May 20, 2026
Earnings Call Sentiment Neutral
The earnings call outlined significant improvements in adjusted EBITDA and wireless revenue growth, driven by strategic partnerships and product developments. However, these positives were tempered by a decline in photonics revenue, challenging macroeconomic conditions, and ongoing financial constraints, indicating a mixed outlook.
Q4-2024 Updates
Positive Updates
Adjusted EBITDA Improvement
Adjusted EBITDA improved significantly from £4.3 million to £8.2 million, reflecting decisive cost actions and increased efficiencies.
Wireless Revenue Growth
Wireless segment revenue increased by 25% to £67.3 million, driven by increased penetration into the Asian market and the Android ecosystem, as well as an increase in GaN sales for 5G infrastructure.
Strategic Partnerships and Product Development
IQE launched a joint development agreement with X-FAB for GaN power in Europe and continued development in MicroLED and Quantum Dot Laser foundry services, strengthening its position in emerging technologies.
Negative Updates
Photonics Revenue Decline
Photonics segment revenue decreased by 16% to £49.9 million, due to softness in the 3D sensing and pixels market.
Macroeconomic and Industry Challenges
The macro environment remains challenging with slow industry recovery, weak global smartphone sales, and geopolitical tensions impacting supply chains.
Ongoing Debt and Financial Constraints
The company faces significant financial constraints with a net debt position and a balance sheet impacted by lease liabilities and interest payments. The strategic review aims to address these issues.
Company Guidance
In the recent IQE full-year results presentation, CEO Jutta Meier emphasized the company's strategic focus on financial discipline and operational agility amidst a challenging macroeconomic environment. The company's revenue for fiscal year 2024 remained stable at £118 million, while adjusted EBITDA improved significantly from £4.3 million to £8.2 million, attributed to decisive cost actions and efficiency improvements. The strategic review aims to make IQE debt-free and allow further investments in growth sectors such as GaN power and display technologies. Despite a 16% decline in Photonics revenue, Wireless revenue increased by 25% to £67.3 million, driven by higher penetration into the Asian market and increased GaN sales for 5G infrastructure. The company's cash position was bolstered by a convertible loan note fundraise, resulting in cash and cash equivalents of £20.6 million at the end of Q1 2025. Looking ahead, IQE expects revenue and adjusted EBITDA for fiscal year 2025 to align with analyst forecasts, with improvements anticipated in the second half of the year, driven by AI-related demand and strategic initiatives.

IQE plc Financial Statement Overview

Summary
IQE plc is facing significant financial challenges. Revenue growth is stagnant, profitability is under pressure with negative margins, and cash flow generation is weak. The balance sheet shows increasing leverage, which could pose risks if operational performance does not improve. The company needs to address cost management and improve operational efficiencies to enhance financial stability.
Income Statement
IQE plc has faced declining revenues, with a 1.5% increase from 2023 to 2024, but a significant drop from 2020 levels. Gross profit margin remains low at 3.77% for 2024, indicating cost pressures. Net profit margin is negative, which is concerning for profitability. The EBIT and EBITDA margins are also negative, reflecting operational challenges and a lack of profitability.
Balance Sheet
The company's debt-to-equity ratio has increased, reaching 0.55 in 2024, suggesting rising financial leverage. Return on Equity is negative due to net losses, indicating poor returns for shareholders. The equity ratio stands at 54.30%, showing a moderate reliance on equity financing, which provides some balance sheet stability.
Cash Flow
The free cash flow growth rate is negative, highlighting deteriorating cash generation capabilities. Operating cash flow to net income ratio is negative due to consistent net losses, indicating cash flow issues. Free cash flow to net income is also negative, underscoring inefficiencies in converting earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue97.27M118.03M115.25M167.50M154.10M178.02M
Gross Profit-2.51M4.45M2.33M26.40M17.64M33.15M
EBITDA-12.33M-6.22M-1.11M-46.68M5.23M19.02M
Net Income-49.14M-38.18M-29.38M-74.50M-31.00M-3.27M
Balance Sheet
Total Assets228.26M247.05M273.51M296.10M351.22M371.29M
Cash, Cash Equivalents and Short-Term Investments16.99M4.66M5.62M11.60M10.79M24.66M
Total Debt86.83M73.99M54.15M77.60M70.98M69.76M
Total Liabilities122.20M112.94M103.73M121.00M116.60M110.85M
Stockholders Equity106.06M134.11M169.78M175.10M234.62M260.44M
Cash Flow
Free Cash Flow-5.08M-17.72M-12.20M-12.00M-3.00M22.92M
Operating Cash Flow2.36M-2.88M5.92M5.90M15.39M33.32M
Investing Cash Flow-6.41M-10.19M-17.96M-10.70M-18.30M-11.77M
Financing Cash Flow13.36M12.16M6.63M4.73M-11.17M-5.55M

IQE plc Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.03
Price Trends
50DMA
5.46
Positive
100DMA
6.43
Positive
200DMA
8.20
Positive
Market Momentum
MACD
0.83
Negative
RSI
83.71
Negative
STOCH
93.94
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IQE, the sentiment is Positive. The current price of 5.03 is below the 20-day moving average (MA) of 5.73, below the 50-day MA of 5.46, and below the 200-day MA of 8.20, indicating a bullish trend. The MACD of 0.83 indicates Negative momentum. The RSI at 83.71 is Negative, neither overbought nor oversold. The STOCH value of 93.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IQE.

IQE plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
£379.40M28.6655.98%121.45%345.83%
73
Outperform
£79.27M19.707.39%36.61%
67
Neutral
£169.70M45.423.13%2.19%10.66%21.19%
66
Neutral
£44.01M37.272.28%3.67%-21.33%-11.35%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
48
Neutral
£102.13M-1.94-37.55%-24.75%-110.79%
44
Neutral
£15.36M-7.03-3.25%-172.09%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IQE
IQE plc
9.87
-1.57
-13.72%
GB:CML
CML Microsystems
265.00
-0.18
-0.07%
GB:FTC
Filtronic
184.00
82.00
80.39%
GB:GHH
Gooch & Housego
620.00
181.80
41.49%
GB:KMK
Kromek Group plc
11.63
6.93
147.34%
GB:NANO
Nanoco Group plc
8.23
-4.56
-35.65%

IQE plc Corporate Events

Business Operations and StrategyFinancial Disclosures
IQE lifts 2025 outlook on defence and AI demand as strategic review draws bidders
Positive
Jan 12, 2026

IQE reported strong trading momentum in the second half of 2025, driven by faster-than-expected funding for US military and defence programmes, robust photonics demand from AI and data centre markets, and higher wireless sales linked to new handset launches, particularly benefiting its Taiwan operations. The company expects full-year 2025 revenue of about £97m and adjusted EBITDA of at least £2.0m, at the upper end of its prior guidance, supported by improved capacity utilisation, a year-end cash position of £15.6m, and a waiver from HSBC on Q4 2025 EBITDA covenant testing; it enters 2026 with a strong first-quarter order book and is advancing a strategic review that has attracted multiple non-binding offers for the group and certain assets, underscoring investor interest but with no certainty of a transaction.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £7.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
IQE Updates Total Voting Rights and Employee Share Plan Allotments
Neutral
Jan 5, 2026

IQE plc has confirmed that as of 31 December 2025 its issued share capital comprised 978,263,616 ordinary shares, of which 4,115 are held in treasury, leaving 978,259,501 ordinary shares in issue with voting rights, a figure investors should use for regulatory disclosure calculations under UK transparency rules. The company also reported on its all-employee share option plan block admission for the period from 1 July to 31 December 2025, during which 1,758,054 new ordinary shares were issued under the scheme, reducing the remaining headroom to 4,773,780 shares, underscoring ongoing employee equity participation and providing clarity to shareholders on potential future dilution from option exercises.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Business Operations and Strategy
IQE Extends Strategic Supply Agreement with Lumentum
Positive
Dec 8, 2025

IQE plc has announced a multi-year extension of its strategic supply agreement with Lumentum Holdings Inc. This extension builds on their longstanding relationship, leveraging IQE’s VCSEL expertise to advance 3D sensing technologies across Lumentum’s photonics product portfolio. These technologies are crucial for consumer, automotive LiDAR, and in-cabin sensing applications. The agreement is expected to foster further innovation in sensing technologies, expanding their application into new consumer and automotive products, thereby strengthening IQE’s position in the semiconductor industry.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Regulatory Filings and Compliance
IQE Announces Total Voting Rights Update
Neutral
Dec 1, 2025

IQE plc announced that as of 30 November 2025, its issued share capital consisted of 977,637,531 ordinary shares, with 4,115 shares held in treasury, resulting in 977,633,416 shares with voting rights. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
IQE plc Grants Share Options to Executive Chair
Neutral
Dec 1, 2025

IQE plc announced that its Executive Chair, Mark Cubitt, has been granted nil cost share options over 166,667 ordinary shares as part of the company’s Long Term Incentive Plan. This grant is part of a series of options that will total 666,667 shares, subject to a three-year holding period. This move is part of IQE’s strategy to align leadership incentives with long-term company performance, potentially impacting its market positioning by reinforcing executive commitment.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.00 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Regulatory Filings and Compliance
IQE plc Announces Total Voting Rights Update
Neutral
Oct 31, 2025

IQE plc announced that as of 31 October 2025, its issued share capital consists of 977,561,878 ordinary shares, with 4,115 shares held in treasury, resulting in 977,557,763 shares with voting rights. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s rules, reflecting the company’s transparency and regulatory compliance.

The most recent analyst rating on (GB:IQE) stock is a Hold with a £5.50 price target. To see the full list of analyst forecasts on IQE plc stock, see the GB:IQE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2026